[CADL] YoY Quarter Result on 31-Mar-2024 [#Q1]

Stock
[CADL] Candel Therapeutics, Inc.
Announcement Date
14-May-2024
Financial Year
2024
Quarter
31-Mar-2024 [#Q1]
Profit Trend
QoQ- 25.90%
YoY- -4.66%
Quarter Report
CADL's Result
CADL's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 CAGR
Revenue 0 0 31 31 31 -
PBT -8,221 -8,795 -874 -4,478 -1,772 46.72%
Tax 208 -940 -8,112 191 72 30.34%
NP -8,221 -7,855 7,238 -4,478 -1,772 46.72%
Tax Rate - - - - - -
Total Cost 8,221 7,855 -7,207 4,509 1,803 46.08%
Ratio Analysis
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 CAGR
NP Margin 0.00 0.00 23,348.39 -14,445.16 -5,716.13 -
Per Share
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 CAGR
EPS -0.28 -0.27 0.25 -0.24 -0.09 32.78%
EPS Diluted -0.28 -0.27 0.25 -0.24 -0.09 32.78%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.